NCAPG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.174400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.037800E-01
Normal-vs-Stage2
4.669000E-01
Normal-vs-Stage3
8.982000E-01
Normal-vs-Stage4
9.599200E-01
Stage1-vs-Stage2
4.953200E-01
Stage1-vs-Stage3
8.647000E-01
Stage1-vs-Stage4
8.217400E-01
Stage2-vs-Stage3
4.692000E-01
Stage2-vs-Stage4
4.313800E-01
Stage3-vs-Stage4
9.407400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.303800E-01
Normal-vs-AfricanAmerican
6.041800E-01
Normal-vs-Asian
2.965000E-01
Caucasian-vs-AfricanAmerican
7.261200E-01
Caucasian-vs-Asian
8.049000E-01
AfricanAmerican-vs-Asian
4.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.100200E-01
Normal-vs-Female
4.931000E-01
Male-vs-Female
1.299190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.494800E-01
Normal-vs-Age(41-60Yrs)
5.367400E-01
Normal-vs-Age(61-80Yrs)
4.614800E-01
Normal-vs-Age(81-100Yrs)
3.716800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.595200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.863970E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.683400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.227200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.246400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.080400E-01
Normal-vs-Daily Drinker
5.345800E-01
Normal-vs-Weekly Drinker
5.846600E-01
Normal-vs-Occasional Drinker
4.535000E-01
Normal-vs-Social Drinker
4.245000E-01
Non Drinker-vs-Daily Drinker
7.137600E-01
Non Drinker-vs-Weekly Drinker
4.951800E-01
Non Drinker-vs-Occasional Drinker
8.867000E-01
Non Drinker-vs-Social Drinker
8.843600E-01
Daily Drinker-vs-Weekly Drinker
4.227000E-01
Daily Drinker-vs-Occasional Drinker
8.209200E-01
Daily Drinker-vs-Social Drinker
6.144200E-01
Weekly Drinker-vs-Occasional Drinker
4.644800E-01
Weekly Drinker-vs-Social Drinker
5.348200E-01
Occasional Drinker-vs-Social Drinker
7.690200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.488000E-01
Normal-vs-Grade 2
5.760400E-01
Normal-vs-Grade 3
5.907600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.695800E-03
Grade 1-vs-Grade 3
2.284700E-03
Grade 1-vs-Grade 4
5.488000E-01
Grade 2-vs-Grade 3
1.427200E-01
Grade 2-vs-Grade 4
5.760400E-01
Grade 3-vs-Grade 4
5.907600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.201600E-01
Normal-vs-NonDiabetic
5.314200E-01
Diabetic-vs-NonDiabetic
2.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.388220E-01
Normal-vs-NoPancreatitis
5.806000E-01
Pancreatitis-vs-NoPancreatitis
4.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.301600E-01
Normal-vs-N1
5.131200E-01
N0-vs-N1
8.262000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.103800E-01
Normal-vs-TP53-NonMutant
6.416600E-01
TP53-Mutant-vs-TP53-NonMutant
6.2208000000008E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
